Evidence map›Paper›PMID 26799072›Full record

ArticlePloS one2016

Evaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy.

Bhagwant Kaur Sekhon, Rebecca Heidi Roubin, Yiming Li, Parimala B Devi, Srinivas Nammi, Kei Fan, Daniel Man-yuen Sze

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Biomedicines · 2020
    Review
  2. Review
  3. Immunomodulatory Properties ofFrontiers in immunology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bhagwant Kaur SekhonFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
Rebecca Heidi RoubinFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
Yiming LiFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
Parimala B DeviFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
Srinivas NammiFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
Kei FanFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
Daniel Man-yuen SzeFaculty of Pharmacy, The University of Sydney, New South Wales, 2006, Australia.
University of Sydney · AUCamden and Campbelltown Hospitals · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polysaccharopeptide (PSP), from Coriolus versicolor, has been used widely as an adjuvant to chemotherapy with demonstrated anti-tumor and broad immunomodulating effects. While PSP's mechanism of action still remains unknown, its enhanced immunomodulatory potential with acacia gum is of great interest. Acacia gum, which also contains polysaccharides and glycoproteins, has been demonstrated to be immunopotentiating. To elucidate whether PSP directly activates T-cell-dependent B-cell responses in vivo, we used a well-established hapten carrier system (Nitrophenyl-chicken gamma globulin (NP-CGG)). 6-week C57BL/6 male mice were immunised with 50 μg of NP25-CGG alum precipitate intraperitoneally. Mice were gavaged daily with 50 mg/kg PSP in a vehicle containing acacia gum and sacrificed at days 0, 4, 7, 10, 14 and 21. ELISA was used to measure the total and relative hapten-specific anti-NP IgA, IgM and IgG titre levels compared to the controls. It was found that PSP, combined with acacia gum, significantly increased total IgG titre levels at day 4 (P< 0.05), decreased IgM titre levels at days 4 and 21 (P< 0.05) with no alterations observed in the IgA or IgE titre levels at any of the time points measured. Our results suggest that while PSP combined with acacia gum appears to exert weak immunological effects through specific T-cell dependent B-cell responses, they are likely to be broad and non-specific which supports the current literature on PSP. We report for the first time the application of a well-established hapten-carrier system that can be used to characterise and delineate specific T-cell dependent B-cell responses of potential immunomodulatory glycoprotein-based herbal medicines combinations in vivo.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodiesB-Lymphocytesgamma-GlobinsGum ArabicHaptensImmunizationImmunoglobulin GImmunoglobulin MImmunotherapyLymphocyte ActivationMaleMiceMice, Inbred C57BLNeoplasms4-hydroxy-5-nitrophenyl acetic acidAdjuvants, ImmunologicAntibodiesgamma-GlobinsGum ArabicHaptensImmunoglobulin GImmunoglobulin MNitrophenolsPhenylacetatespolysaccharide peptideProteoglycans

Identifiers

PMID26799072
PMCPMC4723152
OpenAlexW2259243542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.